TOVAN TRUONG: Open Payments
NPI 1265931281 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,266 in 178 payments from 16 companies in 2025. Trend: 2023 $2,552 · 2024 $2,632 · 2025 $3,266
Food & beverage: $3,185Education: $81
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $474 |
| ABBVIE INC. | 23 | $373 |
| UCB, Inc. | 19 | $332 |
| GENZYME CORPORATION | 8 | $330 |
| LEO Pharma Inc. | 13 | $301 |
| Novartis Pharmaceuticals Corporation | 14 | $299 |
| PFIZER INC. | 21 | $252 |
| Janssen Biotech, Inc. | 12 | $237 |
| Lilly USA, LLC | 14 | $208 |
| Arcutis Biotherapeutics, Inc. | 19 | $166 |
Products named: DUPIXENT, Bimzelx, CIBINQO, TREMFYA, TALTZ, COSENTYX, RINVOQ, SKYRIZI.
Industry payments across OK — which companies pay providers there.
